{"transactions":[{"id":3382,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-03T22:15:08.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":6675,"price":19.1131,"value":127579.9425,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":159378,"source":{"system":"sec-edgar","filing":"0002048588-26-000013","document":"form4-09032026_060903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2048588/000204858826000013/form4-09032026_060903.xml","form_type":"4"}},{"id":717983,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-02T22:44:29.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":4896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions."}],"balance_after":39695,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":4896},"source":{"system":"sec-edgar","filing":"0002048588-26-000010","document":"form4a-07022026_100725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000010/form4a-07022026_100725.xml","form_type":"4/A","original_submission_date":"2026-06-30"}},{"id":717982,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-02T22:44:29.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":false,"shares":5104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions."}],"balance_after":44591,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":5104},"source":{"system":"sec-edgar","filing":"0002048588-26-000010","document":"form4a-07022026_100725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000010/form4a-07022026_100725.xml","form_type":"4/A","original_submission_date":"2026-06-30"}},{"id":717981,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T22:44:29.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":4896,"price":17.0304,"value":83380.8384,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $17.0304 and the range of prices were between $17 and $17.08. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions."}],"balance_after":166053,"source":{"system":"sec-edgar","filing":"0002048588-26-000010","document":"form4a-07022026_100725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000010/form4a-07022026_100725.xml","form_type":"4/A","original_submission_date":"2026-06-30"}},{"id":717980,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T22:44:29.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":4896,"price":5.1,"value":24969.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions."}],"balance_after":170949,"source":{"system":"sec-edgar","filing":"0002048588-26-000010","document":"form4a-07022026_100725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000010/form4a-07022026_100725.xml","form_type":"4/A","original_submission_date":"2026-06-30"}},{"id":717979,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T22:44:29.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":5104,"price":17.0467,"value":87006.3568,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $17.046782 and the range of prices were between $17 and $17.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions."}],"balance_after":166053,"source":{"system":"sec-edgar","filing":"0002048588-26-000010","document":"form4a-07022026_100725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000010/form4a-07022026_100725.xml","form_type":"4/A","original_submission_date":"2026-06-30"}},{"id":717978,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T22:44:29.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":true,"shares":5104,"price":5.1,"value":26030.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions."}],"balance_after":171157,"source":{"system":"sec-edgar","filing":"0002048588-26-000010","document":"form4a-07022026_100725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000010/form4a-07022026_100725.xml","form_type":"4/A","original_submission_date":"2026-06-30"}},{"id":722783,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-06-30T20:46:09.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":4896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."}],"balance_after":39817,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":4896},"source":{"system":"sec-edgar","filing":"0002048588-26-000009","document":"form4-06302026_080605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000009/form4-06302026_080605.xml","form_type":"4"}},{"id":722782,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-06-30T20:46:09.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":false,"shares":4982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."}],"balance_after":44713,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":4982},"source":{"system":"sec-edgar","filing":"0002048588-26-000009","document":"form4-06302026_080605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000009/form4-06302026_080605.xml","form_type":"4"}},{"id":722781,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-30T20:46:09.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":4896,"price":17.0304,"value":83380.8384,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $17.0304 and the range of prices were between $17 and $17.08. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":165931,"source":{"system":"sec-edgar","filing":"0002048588-26-000009","document":"form4-06302026_080605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000009/form4-06302026_080605.xml","form_type":"4"}},{"id":722780,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-30T20:46:09.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":4896,"price":5.1,"value":24969.6,"ownership":{"direct":true},"balance_after":170827,"source":{"system":"sec-edgar","filing":"0002048588-26-000009","document":"form4-06302026_080605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000009/form4-06302026_080605.xml","form_type":"4"}},{"id":722779,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-30T20:46:09.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":5104,"price":17.0467,"value":87006.3568,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $17.046782 and the range of prices were between $17 and $17.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":165931,"source":{"system":"sec-edgar","filing":"0002048588-26-000009","document":"form4-06302026_080605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000009/form4-06302026_080605.xml","form_type":"4"}},{"id":722778,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-30T20:46:09.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":true,"shares":4982,"price":5.1,"value":25408.2,"ownership":{"direct":true},"balance_after":171035,"source":{"system":"sec-edgar","filing":"0002048588-26-000009","document":"form4-06302026_080605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000009/form4-06302026_080605.xml","form_type":"4"}},{"id":751751,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-03T22:00:09.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":6676,"price":12.6071,"value":84164.9996,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":166053,"source":{"system":"sec-edgar","filing":"0002048588-26-000008","document":"form4-06032026_060603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000008/form4-06032026_060603.xml","form_type":"4"}},{"id":843896,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-13T20:15:14.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":110342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":110342,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":110342},"source":{"system":"sec-edgar","filing":"0002048588-26-000005","document":"form4a-03132026_040304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000005/form4a-03132026_040304.xml","form_type":"4/A","original_submission_date":"2026-03-03"}},{"id":867176,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-03T23:45:08.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":70831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026."}],"balance_after":70831,"derivative":{"exercise_price":12.63,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":70831},"source":{"system":"sec-edgar","filing":"0002048588-26-000003","document":"form4-03032026_060304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000003/form4-03032026_060304.xml","form_type":"4"}},{"id":867175,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:08.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":1428,"price":12.3616,"value":17652.3648,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $12.3616 and the range of prices were between $12.20 and $12.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":172729,"source":{"system":"sec-edgar","filing":"0002048588-26-000003","document":"form4-03032026_060304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000003/form4-03032026_060304.xml","form_type":"4"}},{"id":867174,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-03T23:45:08.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":131543,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":174157,"source":{"system":"sec-edgar","filing":"0002048588-26-000003","document":"form4-03032026_060304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000003/form4-03032026_060304.xml","form_type":"4"}},{"id":951508,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-05T23:03:53.000Z","date":"2026-01-02","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."}],"balance_after":49695,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0002048588-26-000002","document":"form4-01052026_110150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000002/form4-01052026_110150.xml","form_type":"4"}},{"id":951507,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-05T23:03:53.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":29.534,"value":590680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $29.534002 and the range of prices were between $29.09 and $30.06. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":42614,"source":{"system":"sec-edgar","filing":"0002048588-26-000002","document":"form4-01052026_110150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000002/form4-01052026_110150.xml","form_type":"4"}},{"id":951506,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-05T23:03:53.000Z","date":"2026-01-02","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":5.1,"value":102000.0,"ownership":{"direct":true},"balance_after":62614,"source":{"system":"sec-edgar","filing":"0002048588-26-000002","document":"form4-01052026_110150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858826000002/form4-01052026_110150.xml","form_type":"4"}},{"id":980310,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-04T21:20:07.000Z","date":"2025-12-02","kind":"sale","planned":false,"acquired":false,"shares":1427,"price":29.3359,"value":41862.3293,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":42614,"source":{"system":"sec-edgar","filing":"0002048588-25-000008","document":"form4-12042025_041203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858825000008/form4-12042025_041203.xml","form_type":"4"}},{"id":1022215,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-10-07T20:15:05.000Z","date":"2025-10-03","kind":"exercise","planned":true,"acquired":false,"shares":4982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."}],"balance_after":69695,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":4982},"source":{"system":"sec-edgar","filing":"0002048588-25-000004","document":"form4-10072025_041001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858825000004/form4-10072025_041001.xml","form_type":"4"}},{"id":1022214,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-07T20:15:05.000Z","date":"2025-10-03","kind":"sale","planned":true,"acquired":false,"shares":1154,"price":22.2778,"value":25708.5812,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $22.2778 and the range of prices were between $22.0438 and $22..47. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":44041,"source":{"system":"sec-edgar","filing":"0002048588-25-000004","document":"form4-10072025_041001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858825000004/form4-10072025_041001.xml","form_type":"4"}},{"id":1022213,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-07T20:15:05.000Z","date":"2025-10-03","kind":"sale","planned":true,"acquired":false,"shares":3828,"price":21.5172,"value":82367.8416,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $21.5172 and the range of prices were between $21.04 and $22.0144. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":45195,"source":{"system":"sec-edgar","filing":"0002048588-25-000004","document":"form4-10072025_041001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858825000004/form4-10072025_041001.xml","form_type":"4"}},{"id":1022212,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-07T20:15:05.000Z","date":"2025-10-03","kind":"exercise","planned":true,"acquired":true,"shares":4982,"price":5.1,"value":25408.2,"ownership":{"direct":true},"balance_after":49023,"source":{"system":"sec-edgar","filing":"0002048588-25-000004","document":"form4-10072025_041001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858825000004/form4-10072025_041001.xml","form_type":"4"}},{"id":1024578,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-10-03T20:31:50.000Z","date":"2025-10-01","kind":"exercise","planned":true,"acquired":false,"shares":15018,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."}],"balance_after":74677,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":15018},"source":{"system":"sec-edgar","filing":"0002048588-25-000003","document":"form4-10032025_081044.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858825000003/form4-10032025_081044.xml","form_type":"4"}},{"id":1024577,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-03T20:31:50.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":100,"price":21.08,"value":2108.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."}],"balance_after":44041,"source":{"system":"sec-edgar","filing":"0002048588-25-000003","document":"form4-10032025_081044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858825000003/form4-10032025_081044.xml","form_type":"4"}},{"id":1024576,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-03T20:31:50.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":14918,"price":20.76,"value":309697.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $20.76 and the range of prices were between $20.03 and $21.03. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":44141,"source":{"system":"sec-edgar","filing":"0002048588-25-000003","document":"form4-10032025_081044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858825000003/form4-10032025_081044.xml","form_type":"4"}},{"id":1024575,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-03T20:31:50.000Z","date":"2025-10-01","kind":"exercise","planned":true,"acquired":true,"shares":15018,"price":5.1,"value":76591.8,"ownership":{"direct":true},"balance_after":59059,"source":{"system":"sec-edgar","filing":"0002048588-25-000003","document":"form4-10032025_081044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204858825000003/form4-10032025_081044.xml","form_type":"4"}},{"id":1044792,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-09-09T20:12:26.000Z","date":"2025-09-08","kind":"exercise","planned":true,"acquired":false,"shares":9900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."}],"balance_after":89695,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":9900},"source":{"system":"sec-edgar","filing":"0001415889-25-023969","document":"form4-09092025_080923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023969/form4-09092025_080923.xml","form_type":"4"}},{"id":1044791,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-09T20:12:26.000Z","date":"2025-09-08","kind":"sale","planned":true,"acquired":false,"shares":9900,"price":21.1264,"value":209151.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $21.126480 and the range of prices were between $21.00 and $21.2933. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":44041,"source":{"system":"sec-edgar","filing":"0001415889-25-023969","document":"form4-09092025_080923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023969/form4-09092025_080923.xml","form_type":"4"}},{"id":1044790,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-09T20:12:26.000Z","date":"2025-09-08","kind":"exercise","planned":true,"acquired":true,"shares":9900,"price":5.1,"value":50490.0,"ownership":{"direct":true},"balance_after":53941,"source":{"system":"sec-edgar","filing":"0001415889-25-023969","document":"form4-09092025_080923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023969/form4-09092025_080923.xml","form_type":"4"}},{"id":1045844,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-09-08T22:15:04.000Z","date":"2025-09-05","kind":"exercise","planned":true,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."}],"balance_after":99595,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001415889-25-023898","document":"form4-09082025_060901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023898/form4-09082025_060901.xml","form_type":"4"}},{"id":1045843,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-08T22:15:04.000Z","date":"2025-09-05","kind":"sale","planned":true,"acquired":false,"shares":100,"price":21,"value":2100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."}],"balance_after":44041,"source":{"system":"sec-edgar","filing":"0001415889-25-023898","document":"form4-09082025_060901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023898/form4-09082025_060901.xml","form_type":"4"}},{"id":1045842,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-08T22:15:04.000Z","date":"2025-09-05","kind":"exercise","planned":true,"acquired":true,"shares":100,"price":5.1,"value":510.0,"ownership":{"direct":true},"balance_after":44141,"source":{"system":"sec-edgar","filing":"0001415889-25-023898","document":"form4-09082025_060901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023898/form4-09082025_060901.xml","form_type":"4"}},{"id":1047911,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-04T22:45:05.000Z","date":"2025-09-02","kind":"sale","planned":false,"acquired":false,"shares":1462,"price":18.8632,"value":27577.9984,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $18.8632 and the range of prices were between $18.58 and $19.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":44041,"source":{"system":"sec-edgar","filing":"0001415889-25-023742","document":"form4-09042025_060901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023742/form4-09042025_060901.xml","form_type":"4"}},{"id":1055686,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-08-26T20:29:44.000Z","date":"2025-08-22","kind":"exercise","planned":true,"acquired":false,"shares":4413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."}],"balance_after":99695,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":4413},"source":{"system":"sec-edgar","filing":"0001415889-25-023023","document":"form4-08262025_080841.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023023/form4-08262025_080841.xml","form_type":"4"}},{"id":1055685,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-26T20:29:44.000Z","date":"2025-08-22","kind":"sale","planned":true,"acquired":false,"shares":4413,"price":17.014,"value":75082.782,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $17.0140 and the range of prices were between $17.00 and $17.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":45503,"source":{"system":"sec-edgar","filing":"0001415889-25-023023","document":"form4-08262025_080841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023023/form4-08262025_080841.xml","form_type":"4"}},{"id":1055684,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-26T20:29:44.000Z","date":"2025-08-22","kind":"exercise","planned":true,"acquired":true,"shares":4413,"price":5.1,"value":22506.3,"ownership":{"direct":true},"balance_after":49916,"source":{"system":"sec-edgar","filing":"0001415889-25-023023","document":"form4-08262025_080841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925023023/form4-08262025_080841.xml","form_type":"4"}},{"id":1060260,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-08-21T01:30:05.000Z","date":"2025-08-19","kind":"exercise","planned":true,"acquired":false,"shares":5587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."}],"balance_after":104108,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":5587},"source":{"system":"sec-edgar","filing":"0001415889-25-022539","document":"form4-08202025_090801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925022539/form4-08202025_090801.xml","form_type":"4"}},{"id":1060259,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-21T01:30:05.000Z","date":"2025-08-19","kind":"sale","planned":true,"acquired":false,"shares":5587,"price":17.0345,"value":95171.7515,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $17.034505 and the range of prices were between $17.00 and $17.095. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":45503,"source":{"system":"sec-edgar","filing":"0001415889-25-022539","document":"form4-08202025_090801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925022539/form4-08202025_090801.xml","form_type":"4"}},{"id":1060258,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-21T01:30:05.000Z","date":"2025-08-19","kind":"exercise","planned":true,"acquired":true,"shares":5587,"price":5.1,"value":28493.7,"ownership":{"direct":true},"balance_after":51090,"source":{"system":"sec-edgar","filing":"0001415889-25-022539","document":"form4-08202025_090801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925022539/form4-08202025_090801.xml","form_type":"4"}},{"id":1122930,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-04T23:30:13.000Z","date":"2025-06-02","kind":"sale","planned":false,"acquired":false,"shares":136,"price":18.691,"value":2541.976,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $18.691 and the range of prices were between $18.69 and $18.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":45503,"source":{"system":"sec-edgar","filing":"0001415889-25-015667","document":"form4-06042025_070608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925015667/form4-06042025_070608.xml","form_type":"4"}},{"id":1122929,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-04T23:30:13.000Z","date":"2025-06-02","kind":"sale","planned":false,"acquired":false,"shares":951,"price":18.1489,"value":17259.6039,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $18.1489 and the range of prices were between $17.62 and $18.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":45639,"source":{"system":"sec-edgar","filing":"0001415889-25-015667","document":"form4-06042025_070608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925015667/form4-06042025_070608.xml","form_type":"4"}},{"id":1122928,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-04T23:30:13.000Z","date":"2025-06-02","kind":"sale","planned":false,"acquired":false,"shares":410,"price":17.028,"value":6981.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $17.028 and the range of prices were between $16.62 and $17.56. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":46590,"source":{"system":"sec-edgar","filing":"0001415889-25-015667","document":"form4-06042025_070608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925015667/form4-06042025_070608.xml","form_type":"4"}},{"id":1235827,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-03T22:45:08.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":71000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from February 27, 2025."}],"balance_after":71000,"derivative":{"exercise_price":19.91,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":71000},"source":{"system":"sec-edgar","filing":"0001415889-25-006231","document":"form4-03032025_050304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925006231/form4-03032025_050304.xml","form_type":"4"}},{"id":1235826,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-03T22:45:08.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":47000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":47000,"source":{"system":"sec-edgar","filing":"0001415889-25-006231","document":"form4-03032025_050304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925006231/form4-03032025_050304.xml","form_type":"4"}},{"id":1287391,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-04T01:30:08.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":186203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":186203,"derivative":{"exercise_price":17,"expiration_date":"2035-01-28","underlying":"Common Stock","underlying_shares":186203},"source":{"system":"sec-edgar","filing":"0001415889-25-002816","document":"form4-02032025_080204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002816/form4-02032025_080204.xml","form_type":"4"}},{"id":1287390,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-04T01:30:08.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":109695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":109695,"derivative":{"exercise_price":5.1,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":109695},"source":{"system":"sec-edgar","filing":"0001415889-25-002816","document":"form4-02032025_080204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002816/form4-02032025_080204.xml","form_type":"4"}},{"id":1287389,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-04T01:30:08.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":166542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to this option shall vest one year after August 1, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":166542,"derivative":{"exercise_price":7.51,"expiration_date":"2032-07-31","underlying":"Common Stock","underlying_shares":166542},"source":{"system":"sec-edgar","filing":"0001415889-25-002816","document":"form4-02032025_080204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002816/form4-02032025_080204.xml","form_type":"4"}},{"id":1289521,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":2352,"kind":"person","name":"Feider Stephen","position":1,"cik":"0002048588","reported_name":"Feider Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-31T21:30:36.000Z","date":"2025-01-29","kind":"grant","planned":false,"acquired":true,"shares":186203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":186203,"derivative":{"exercise_price":17,"expiration_date":"2035-01-28","underlying":"Class B Common Stock","underlying_shares":186203},"source":{"system":"sec-edgar","filing":"0001415889-25-002479","document":"form4-01312025_090132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002479/form4-01312025_090132.xml","form_type":"4"}}]}